Nucleai
Ofek Arviv began working as a Research Assistant at Tel Aviv Medical Center in July 2021, and concluded their role in October 2021. They then joined Nucleai in February 2022 as a Medical Data Specialist.
Ofek Arviv attended Tel Aviv University from 2019 to 2026, where they pursued a Doctor of Medicine (MD) degree in the field of Medicine.
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.